Research News
View articles by month and year
-
New Screening Device for Dense Breasts Approved by FDA
The FDA has approved an automated ultrasound device to screen for breast cancer in women with dense breasts.
-
Mammograms Save Lives, Benefits Outweigh Concerns
A European study has found that for every 1,000 women between the ages of 50 and 70 who get a mammogram every 2 years, seven to nine lives are saved.
-
Radiation in Diagnostic Tests Increases Risk for Women with Abnormal BRCA1 or BRCA2 Genes
A new study suggests that diagnostic tests that use radiation done before age 30 in young women with an abnormal BRCA1 or BRCA2 gene increases breast cancer risk.
-
Genetic Counseling Before Surgery Can Lower Stress and Help Women Make Decisions
A small study has found that women diagnosed with breast cancer who are offered genetic counseling before breast cancer surgery have less stress and make more informed decisions about treatment compared to women who don’t get genetic counseling before surgery.
-
New BRCA1 and BRCA2 Test May Be More Accurate, Less Expensive
A group of Canadian scientists has developed a new way to test for abnormal BRCA1 and BRCA2 genes that seems to be more accurate and less expensive than the current testing methods.
-
Mammogram Rates Have Dropped After Task Force Recommendation
A study found that fewer women in their 40s are getting screening mammograms since the U.S. Preventive Services Task Force recommended that screening mammograms start at age 50 instead of 40.
-
FDA Advisory Panel Approves MarginProbe System
An FDA expert panel voted to approve the MarginProbe system - a device that helps surgeons decide if all the cancer tissue has been removed during lumpectomy.
-
AMA Updates Mammogram Policy, Says Screening Should Start at 40
The American Medical Association's new policy says that all women should be eligible for screening mammograms starting at age 40 and that all insurance plans should cover the cost of the screening.
-
Breast Cancer’s Hormone Receptor and HER2 Status Can Change After Diagnosis
The characteristics of a breast cancer -- including hormone receptor status and HER2 status -- can change over time. These changes may happen because the cancer cells change themselves or because treat...
-
Circulating Tumor Cells Linked to Worse Prognosis in Early-Stage Disease
A study has found that circulating tumor cells in the bloodstream are linked to worse prognosis in people diagnosed with early-stage breast cancer.
